Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Can DIY Medicine Tame Rampaging Healthcare Costs?

Simon M. Helfgott, MD  |  Issue: April 2015  |  April 1, 2015

In plain English, Theranos does not anticipate requiring physician referrals for their tests. Some lab testing may evolve as a direct-to-consumer activity.

Holmes is not alone in her thinking. Delos M. Cosgrove, MD, president and chief operating officer of the Cleveland Clinic in Ohio and a noted expert on U.S. healthcare, predicts that blood tests for many common health issues, including high cholesterol and diabetes, will soon be initiated by patients, as well as by doctors.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The CVSs and the Walgreens and the Walmarts of the world are going to be taking a lot of things that currently go to primary care physicians,” Dr. Cosgrove said. “The impact of that on our industry will be enormous.”2

Will the Food and Drug Administration sanction consumer-directed testing? Recently, it has approved DIY genetic testing for certain autosomal recessive genes, but it has yet to issue its final ruling on tests for which the results can have immediate effects on patient healthcare choices.4 Stay tuned.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A Trip Abroad

Joint replacement surgery has been one of the truly great advances in medical care over the past 50 years. Paradoxically, despite the more skillful surgical techniques, shorter hospital stays, better-designed implants and rising volumes of patients undergoing these procedures (1 million annually), the cost of joint arthroplasty continues to rise. Why? Orthopedic procedures have been plagued by the common medical malady of “sticky” pricing, where costs remain high or increase over time instead of dropping. For example, the list price of a total hip implant rose nearly threefold from 1998 to 2011.5 This spurs some patients to seek care in fairly exotic locales, such as Thailand, Hungary, India, Singapore and Malaysia, countries that happen to be the most sought-after destinations for Americans looking for less costly options for joint arthroplasty, spinal fusion, bariatric surgery and cosmetic procedures.

Such organizations as Patients Beyond Borders tout the virtues of medical tourism, especially the ability to receive excellent care at substantial cost markdowns compared with American prices.6

Oh yes, getting some travel time is a nice additional perk. But how patients deal with delayed post-operative complications is not easily addressed.

Medical tourism has its limits, but the concept of seeking quality orthopedic care at reasonable cost has spurred some interesting innovations. It may have persuaded several major hospitals to set fixed, discounted prices for joint arthroplasty procedures for some of the nation’s largest employers. Walmart, Pepsico and Lowe’s have created an alliance with four hospitals that will offer no-cost knee- and hip-replacement surgeries for more than 1.5 million employees and their dependents. But wait! Not only will employees receive consultations and treatment without deductibles or co-insurance, their travel, lodging and living expenses, as well as those of their companion, will also be covered.7 Pack your bags. You may soon be traveling to Baltimore or Springfield, Mo., for that total knee replacement.

Does the Crowd Know Best?

Errors in navigation can have fatal consequences. This was especially true in earlier times, when ships were lost at sea at an alarming rate due to an inability of sailors to track a ship’s correct longitude. For this reason, in 1714 the British Parliament passed the Longitude Act, which offered a substantial prize to anyone who could solve the problem of identifying a ship’s longitudinal position.8 Many proposals were submitted from all parts of Europe, and over the years, the prize was awarded to several individuals for their creative solutions. Some consider this nautical challenge to be one of the first examples of effective crowdsourcing.

Crowdsourcing works because it draws on the curiosity & the altruistic impulses of the human spirit. This creative approach will likely cultivate the growth of open source science, allowing investigators to share ideas & resolve many challenging research issues relatively quickly & at low cost.

Nowadays, crowdsourcing research has enabled investigators to engage thousands of people to provide data or perform data analysis. It has been highly effective in solving some critical problems in molecular biology, comparative genomics, pathology and radiology. In one study, trained participants were able to outperform computer-generated algorithms in solving complex protein-structure prediction problems.8 On the clinical side, another study found that participants were able to correctly classify colonic polyps on computed tomography imaging studies and accurately identify red blood cells infected with malaria parasites over 99% of the time.8

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:costsHealth InsuranceHelfgottMedicationprescription drugrheumatologysurgical procedure

Related Articles

    Technological Advances Linked to Medical Misadventures

    April 15, 2016

    For keen students of American politics, the unending intrigue of the 2016 presidential race has been riveting. With an assemblage of aspiring candidates that, at its start, included a bevy of U.S. senators and former governors, a media-savvy real estate mogul, a renowned Hopkins neurosurgeon and an ophthalmologist, political junkies among us have feasted on…

    Crowdsourcing: The Modern Consult Equivalent

    October 13, 2015

    Two of the great traditions of medicine are the curbside and party consults. In the former, participating physicians informally discuss an especially difficult diagnostic problem. During the latter, a patient will approach the doctor to ask about some possible medical problem and what they should do about it. The advent of the Internet has brought…

    Theranos Lab May Pose Jeopardy to Patient Health

    February 1, 2016

    (Reuters)—Deficient practices at a lab operated by blood-testing startup Theranos pose “immediate jeopardy to patient health and safety,” the U.S. government’s Centers for Medicare & Medicaid Services said in a letter to the company released on Wednesday. Theranos, founded and led by Elizabeth Holmes, has been in the spotlight after reports in the Wall Street…

    Corona Borealis Studio / shutterstock.com

    The Reliability & Utility of Serological Antibody Tests in COVID-19

    September 11, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences